• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Pelthos Doses First Patient in Phase 1b/2a CT2000 Eye Pain Trial

    GLOBENEWSWIRE

    Ligand Completes Merger with Channel Therapeutics

    GLOBENEWSWIRE

    Pelthos Completes Merger, Closes $50.1M Private Placement

    GLOBENEWSWIRE

    Channel Therapeutics Announces Reverse Common Stock Split

    GLOBENEWSWIRE

    Channel Therapeutics Shows Eye Pain Relief via NaV1.7 Inhibitor

    GLOBENEWSWIRE

    Channel Therapeutics Announces 2024 Report for NYSE Compliance

    GLOBENEWSWIRE

    Ligand`s Pelthos Therapeutics to Merge with Channel Therapeutics

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.